[1] Dutt S, Narla A, Lin K, Mullally A, Abayasekara N, Megerdichian C, et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood, The Journal of the American Society of Hematology. 2011;117(9):2567-76. https://doi.org/10.1182/blood-2010-07-295238.
[2] Aspesi A, Pavesi E, Ferrante D. THE RIBOSOMAL BASIS OF DIAMOND-BLACKFAN ANEMIA: MUTATION AND DATABASE UPDATE.2010;31(12):1269-79. http://dx.doi.org/10.1002/humu.21383.
[3] Lahoti A, Harris YT, Speiser PW, Atsidaftos E, Lipton JM, Vlachos A. Endocrine dysfunction in Diamond–Blackfan anemia (DBA): A report from the DBA Registry (DBAR). Pediatric blood & cancer. 2016;63(2):306-12. https://doi.org/10.1002/pbc.25780.
[4] McFarren A, Jayabose S, Ozkaynak MF, Tugal O, Sandoval C. Cleft palate, bilateral external auditory canal atresia, and other midline defects associated with Diamond-Blackfan anemia: case report. Journal of pediatric hematology/oncology. 2007;29(5):338-40. doi: 10.1097/MPH.0b013e31805d8f45.
[5] Bessler M, Mason P, Link D, DB W. Inherited bone marrow failure syndromes. In: Orkin S, Fishe r DE, Ginsburg D, Look A, Lux S, Nathan D, editors. Nathan and Oski’s hematology and oncology of infancy and childhood. Philadelphia: Saunders Elseviers; 2015.
[6] Ball SE, McGuckin CP, Jenkins G, Gordon-Smith EC. Diamond-Blackfan anaemia in the UK: analysis of 80 cases from a 20-year birth cohort. British journal of haematology. 1996;94(4):645-53. https://doi.org/10.1046/j.1365-2141.1996.d01-1839.x.
[7] Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, Ramenghi U, et al. Participants of Sixth Annual Daniella Maria Arturi International Consensus Conference. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol. 2008;142(6):859-76. DOI: 10.1111/j.1365-2141.2008.07269.x.
[8] Halperin DS, Freedman MH. Diamond-blackfan anemia: etiology, pathophysiology, and treatment. The American journal of pediatric hematology/oncology. 1989;11(4):380-94.
[9] Willig TN, Niemeyer CM, Leblanc T, Tiemann C, Robert A, Budde J, et al. Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. Pediatric research. 1999;46(5):553. https://doi.org/10.1203/00006450-199911000-00011.
[10] Aneke JC, Okocha CE. Blood transfusion safety; current status and challenges in Nigeria. Asian journal of transfusion science. 2017;11(1):1-5. doi: 10.4103/0973-6247.200781.
[11] Gordon RR, Varadi S. Congenital hypoplastic anaemia (pure red-cell anaemia) with periodic erythroblastopenia. The Lancet. 1962;279(7224):296-9. https://doi.org/10.1016/S0140-6736(62)91245-X.
[12] Guillozet N, JF M. Congenital hypoplastic red cell anaemia of childhood:(the Blackfan-diamond syndrome). Case report, diagnosis and management.
[13] Wranne L. Transient erythroblastopenia in infancy and childhood. Scandinavian journal of haematology. 1970;7(2):76-81. https://doi.org/10.1111/j.1600-0609.1970.tb01872.x.